| No. of patients | % |
---|---|---|
Total number of patients | 132 | Â |
Sex | Â | Â |
   Male | 79 | 59.8 |
   Female | 53 | 40.2 |
Median age(range) | 62(26-83) | Â |
   <60 | 52 | 39 |
   ≥60 | 80 | 61 |
CEA | Â | Â |
   ≤5 ng/mL | 99 | 75.6 |
   >5 ng/mL | 32 | 24.4 |
Tumor size | Â | Â |
   <5 cm | 58 | 43.9 |
   ≥5 cm | 74 | 56.1 |
Lymph node ratio | Â | Â |
   pNr1 0.01-0.11 | 103 | 78 |
   pNr2 0.12-0.24 | 17 | 12.9 |
   pNr3 0.25-0.92 | 12 | 9.1 |
Primary Tumor | Â | Â |
   pT1 | 12 | 9.1 |
   pT2 | 19 | 14.4 |
   pT3 | 90 | 68.2 |
   pT4 | 11 | 8.3 |
Regional Lymph nodes | Â | Â |
   N0 | 75 | 56.8 |
   N1 | 36 | 27.3 |
   N2 | 21 | 15.9 |
Differentiation | Â | Â |
   Well | 67 | 50.8 |
   Moderate | 52 | 39.4 |
   Poor | 5 | 3.8 |
   Mucinous | 8 | 6.1 |
TNM stage | Â | Â |
   Stage I | 27 | 20.5 |
   StageII | 48 | 36.4 |
   StageIII | 57 | 43.2 |